Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

1.

Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.

Wang KF, Huang PH, Chiang CH, Hsu CY, Leu HB, Chen JW, Lin SJ.

Coron Artery Dis. 2013 Jan;24(1):23-8. doi: 10.1097/MCA.0b013e32835aab4a.

PMID:
23151854
[PubMed - indexed for MEDLINE]
2.

Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.

Wu TC, Leu HB, Lin WT, Lin CP, Lin SJ, Chen JW.

Eur J Clin Invest. 2005 Sep;35(9):537-45.

PMID:
16128859
[PubMed - indexed for MEDLINE]
3.

Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization.

Eckart RE, Uyehara CF, Shry EA, Furgerson JL, Krasuski RA.

J Interv Cardiol. 2004 Feb;17(1):27-31.

PMID:
15009768
[PubMed - indexed for MEDLINE]
4.

Potential role of plasma myeloperoxidase level in predicting long-term outcome of acute myocardial infarction.

Kaya MG, Yalcin R, Okyay K, Poyraz F, Bayraktar N, Pasaoglu H, Boyaci B, Cengel A.

Tex Heart Inst J. 2012;39(4):500-6.

PMID:
22949765
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.

Huang SS, Huang PH, Chen YH, Sung SH, Chiang KH, Chen JW, Lin SJ.

Coron Artery Dis. 2008 Dec;19(8):597-602. doi: 10.1097/MCA.0b013e3283155579.

PMID:
18971786
[PubMed - indexed for MEDLINE]
6.

Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.

Farzaneh-Far A, Phillips HR, Shaw LK, Starr AZ, Fiuzat M, O'Connor CM, Sastry A, Shaw LJ, Borges-Neto S.

JACC Cardiovasc Imaging. 2012 Jul;5(7):715-24. doi: 10.1016/j.jcmg.2012.01.019.

PMID:
22789940
[PubMed - indexed for MEDLINE]
Free Article
7.

High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.

Herrmann J, Lennon RJ, Barsness GW, Sandhu GS, Gulati R, Best PJ, Sorajja P, Bresnahan JF, Mathew V, Bell MR, Prasad A.

Circ Cardiovasc Interv. 2012 Dec;5(6):783-90. doi: 10.1161/CIRCINTERVENTIONS.112.972182. Epub 2012 Dec 4.

PMID:
23212397
[PubMed - indexed for MEDLINE]
Free Article
8.

The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.

Kapur A, Bartolini D, Finlay MC, Qureshi AC, Flather M, Strange JW, Hall RJ.

J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32.

PMID:
19797974
[PubMed - indexed for MEDLINE]
9.

Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.

Fukuda D, Shimada K, Tanaka A, Kusuyama T, Yamashita H, Ehara S, Nakamura Y, Kawarabayashi T, Iida H, Yoshiyama M, Yoshikawa J.

Am J Cardiol. 2006 Jan 15;97(2):175-80. Epub 2005 Nov 17.

PMID:
16442358
[PubMed - indexed for MEDLINE]
10.

Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.

Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB; Intermountain Heart Collaborative (IHC) Study Group.

Am J Cardiol. 2002 Jan 15;89(2):145-9.

PMID:
11792332
[PubMed - indexed for MEDLINE]
11.

Association of adiponectin with future cardiovascular events in patients after acute myocardial infarction.

Huang SS, Huang PH, Chen YH, Chiang KH, Chen JW, Lin SJ.

J Atheroscler Thromb. 2010 Mar 31;17(3):295-303. Epub 2010 Feb 26.

PMID:
20185863
[PubMed - indexed for MEDLINE]
Free Article
12.

Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization.

Nusca A, Patti G, Marino F, Mangiacapra F, D'Ambrosio A, Di Sciascio G.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):377-84. doi: 10.1002/ccd.23185. Epub 2011 Jun 16.

PMID:
21681905
[PubMed - indexed for MEDLINE]
13.

Impact of low levels of vascular endothelial growth factor after myocardial infarction on 6-month clinical outcome. Results from the Nagoya Acute Myocardial Infarction Study.

Matsudaira K, Maeda K, Okumura N, Yoshikawa D, Morita Y, Mitsuhashi H, Ishii H, Kondo T, Murohara T; Nagoya Acute Myocardial Infarction Study (NAMIS) Group.

Circ J. 2012;76(6):1509-16. Epub 2012 Mar 27.

PMID:
22452999
[PubMed - indexed for MEDLINE]
Free Article
14.

Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.

Eldrup N, Kragelund C, Steffensen R, Nordestgaard BG.

Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):677-83. doi: 10.1016/j.numecd.2010.11.003. Epub 2010 Dec 30.

PMID:
21194909
[PubMed - indexed for MEDLINE]
15.

Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox).

Cho KH, Jeong MH, Ahn Y, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry Investigators.

Am J Cardiol. 2010 Oct 15;106(8):1061-8. doi: 10.1016/j.amjcard.2010.06.009.

PMID:
20920639
[PubMed - indexed for MEDLINE]
16.

Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.

Yasuda S, Miyazaki S, Kinoshita H, Nagaya N, Kanda M, Goto Y, Nonogi H.

Clin Sci (Lond). 2007 Jan;112(1):43-9.

PMID:
16939410
[PubMed - indexed for MEDLINE]
Free Article
17.

Non-high-density lipoprotein cholesterol is a practical predictor of long-term cardiac death after coronary artery bypass grafting.

Fukushima Y, Ohmura H, Mokuno H, Kajimoto K, Kasai T, Hirayama S, Miyauchi K, Miida T, Amano A, Daida H.

Atherosclerosis. 2012 Mar;221(1):206-11. doi: 10.1016/j.atherosclerosis.2011.12.012. Epub 2011 Dec 27.

PMID:
22245035
[PubMed - indexed for MEDLINE]
18.

Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.

Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, Inada T, Mitsuoka H, Taniguchi R, Nakano A, Kita T, Sakata R, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.

Circ J. 2012;76(6):1369-79. Epub 2012 Mar 15.

PMID:
22447012
[PubMed - indexed for MEDLINE]
Free Article
19.

Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome.

Dhillon OS, Khan SQ, Narayan HK, Ng KH, Mohammed N, Quinn PA, Squire IB, Davies JE, Ng LL.

Clin Sci (Lond). 2009 Nov 9;118(4):249-57. doi: 10.1042/CS20090226.

PMID:
19583569
[PubMed - indexed for MEDLINE]
Free Article
20.

Soluble receptor of advanced glycated endproducts is associated with plaque vulnerability in patients with acute myocardial infarction.

Park HJ, Baek JY, Shin WS, Kim DB, Jang SW, Shin DI, Koh YS, Seo SM, Uhm JS, Kim TH, Kim CJ, Kim PJ, Chang K, Chung WS, Seung KB, Lee JM.

Circ J. 2011;75(7):1685-90. Epub 2011 May 17.

PMID:
21576827
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk